As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.
Now, with the full introduction of the EU Clinical Trials Regulation, you need to handle increased transparency requirements on top of the existing requirements under Health Canada Public Release of Clinical Information and future requirements under EMA Policy 0070.
In this webinar, Niamh McGuinness, Clinical Trial Transparency Expert at Privacy Analytics, showcases Privacy Analytics’ Mirage software. It’s powered by natural language processing and can deliver high-speed redaction or statistical anonymization, helping you meet your regulatory submission deadlines while protecting privacy.
You’ll see a product demonstration and find out which of three solution options best meets your most pressing clinical document submission needs: Redaction-as-a-Service, Anonymization-as-a-Service, or a license option.